ASX Announcement 28 October 2026 BCAL welcomes Dr John Melki’s appointment to GSS Board and reiterates merger concerns BCAL Diagnostics Limited (ASX: BDX) (BCAL), an Australian healthcare company pioneering diagnostics for early detection of cancer. BCAL a major shareholder in Genetic Signatures...